Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tears Again (Optima Pharma)
- Development stage
- Unknown
- Lead developer
- Optima Pharmazeutische
- Modality
- Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic, Topical
01
Overview
Tears Again is a liposomal eye spray developed by Optima Pharmaceutical GmbH, designed to treat dry eye disease by stabilizing the tear film's lipid layer. The formulation consists of phospholipid liposomes enriched with vitamins A and E, which are applied as a spray onto closed eyelids. Upon application, the liposomes migrate across the eyelid margins to integrate into the tear film, effectively mimicking the natural function of meibomian glands and reducing tear evaporation by up to 95%. It is particularly indicated for evaporative dry eye and tear film lipid deficiency, offering a preservative-free option compatible with contact lenses.
- Brand names
- Tears Again
- Other names
- Tears Again Liposomal Spray
02
Targets
Ocular surface lipid-aqueous/mucin interface
Beyond the preview
Go deeper on Tears Again (Optima Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tears Again (Optima Pharma).